In heterogeneous catalysis, the catalyst is in a different phase from the reactants. Recommanded Product: 2213-63-0, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 2213-63-0, name is 2,3-Dichloroquinoxaline. In an article£¬Which mentioned a new discovery about 2213-63-0
Synthesis of some new pyrimido[2?,1?:2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents
Treatment of 6-aminothiouracil (1) with 2,3-dichloroquinoxaline (2) in ethanol/TEA afforded 6-amino-2-(3-chloroquinoxalin-2-ylthio)pyrimidin-4(3H)-one (3), which was refluxed in DMF to give 2-aminopyrimido[2?,1?:2,3]thiazolo[4,5-b]quinoxaline-4-one (4). Compound 4 was utilized as a key intermediate for the synthesis of a new pyrimido[2?,1?:2,3]thiazolo[4,5-b]quinoxaline derivatives 5-14 via the reaction with 2-chlorobenzaldehyde, 2-chlorocyclohex-1-enecarbaldehyde, 2-chlorobenzoic acid, 2,4-dichlorobenzoic acid, 5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehyde, 2-chloro-4,6-dimethylnicotinonitrile, alpha,beta-unsaturated ketones and isonicotinaldehyde, respectively. The chemical structures of the newly synthesized compounds were characterized by IR, NMR and mass spectral analysis. These compounds were also screened for their analgesic and anti-inflammatory activities. Some of these compounds (3, 4, 9, 10 and 12-14) exhibited promising activities.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 2213-63-0, help many people in the next few years.Recommanded Product: 2213-63-0
Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1234 | ChemSpider